Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH.

Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.

2.

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH.

Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21.

3.

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH.

Alzheimers Dement. 2011 May;7(3):257-62. doi: 10.1016/j.jalz.2011.03.004. Epub 2011 Apr 21.

4.

The genetics of Alzheimer disease: back to the future.

Bertram L, Lill CM, Tanzi RE.

Neuron. 2010 Oct 21;68(2):270-81. doi: 10.1016/j.neuron.2010.10.013. Review.

5.

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.

Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K.

Nat Rev Drug Discov. 2010 Jul;9(7):560-74. doi: 10.1038/nrd3115. Review.

PMID:
20592748
6.

Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia.

Jagust W.

Alzheimers Dement. 2006 Jan;2(1):36-42. doi: 10.1016/j.jalz.2005.11.002.

PMID:
19595854
7.

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Ann Neurol. 2009 Apr;65(4):403-13. doi: 10.1002/ana.21610.

8.

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC.

Brain. 2008 Mar;131(Pt 3):665-80. doi: 10.1093/brain/awm336. Epub 2008 Feb 7.

9.

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P.

Lancet Neurol. 2007 Aug;6(8):734-46. Review.

PMID:
17616482
10.

Early Alzheimer's disease genetics.

Schellenberg GD.

J Alzheimers Dis. 2006;9(3 Suppl):367-72.

PMID:
16914874
11.

Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.

Lyketsos CG, Colenda CC, Beck C, Blank K, Doraiswamy MP, Kalunian DA, Yaffe K; Task Force of American Association for Geriatric Psychiatry.

Am J Geriatr Psychiatry. 2006 Jul;14(7):561-72. No abstract available. Erratum in: Am J Geriatr Psychiatry. 2006 Sep;14(9):808.

PMID:
16816009
12.

Neuropathologic features of amnestic mild cognitive impairment.

Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E.

Arch Neurol. 2006 May;63(5):665-72.

PMID:
16682536
13.

Neuropathologic substrate of mild cognitive impairment.

Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR.

Arch Neurol. 2006 Jan;63(1):38-46.

PMID:
16401735
14.

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM.

Ann Neurol. 2006 Mar;59(3):512-9.

PMID:
16372280
15.

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS.

Neurology. 2005 Mar 8;64(5):834-41.

PMID:
15753419
16.

Defining molecular targets to prevent Alzheimer disease.

Selkoe DJ.

Arch Neurol. 2005 Feb;62(2):192-5. Review. No abstract available.

PMID:
15710846
17.

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.

Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, B├Ąckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC.

J Intern Med. 2004 Sep;256(3):240-6. Review.

18.

Mild cognitive impairment as a diagnostic entity.

Petersen RC.

J Intern Med. 2004 Sep;256(3):183-94. Review.

19.

Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review.

Atiya M, Hyman BT, Albert MS, Killiany R.

Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17(3):177-95. Review. No abstract available.

PMID:
14512832
20.

CSF markers for incipient Alzheimer's disease.

Blennow K, Hampel H.

Lancet Neurol. 2003 Oct;2(10):605-13. Review.

PMID:
14505582

Supplemental Content

Support Center